#Sars

Mac n’ Chise 🧬🧫🦠

sailorrooscout

Good mRNA vaccine news this morning! Ben Osborn, the UK head of Pfizer, said they do not expect to have to change their vaccine to handle SARS-CoV-2 variants B.1.1.17 and

Gabriel Bosslet

gbosslet

There is chatter about this study in @nature that "disproves" asymptomatic spread- ergo, lockdowns were unneeded.Let's unpack this because I think this is a blatant misinterpretation of this amazing study.https://go.nature.com

el gato malo

boriquagato

this has been my bet for some time: when this is all said and done, there is going to be a strong source contamination fecal/oral route infection pathway for covid19.the

Priyanka Shukla

PriyankaJShukla

CKJ 2. कोरोना वायरस क्या है? #कोरोना व #COVID19 में क्या अंतर है?#कोरोना_वायरस का पूरानाम SARS-CoV-2 वायरस है।

Peter Higgins

ibddoctor

THREAD: More data about PPIs and SARS-CoV-2 coming out. Is there a consistent association across studies? @statsepi @DrToddLee @supermarioelia @mikejohansenmd @ADAlthousePhD Increased prevalence of ARDS in those taking PPI at

Concerned Citizen

Concern14923094

The current "GOLD STANDARD" for Schools and Education !America leads by example.Operational Strategy for K-12 Schools through Phased Mitigationhttps://www.cdc.gov/coronavirus/2019-ncov/downloads/community/schools-childcare/K-12-Op

Timothée Bruel

Timothee_B

Here is the thread of our new pre-print Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies 1/16https://www.biorxiv.org/content/10.1101/2021.02.12.430472v1 In this study, we compared the sensitivity

Simply Biochemistry

SimplyBiochem

1) THREAD - A summary of NERVTAG’s (the U.K. virus committee who advise the government) opinions on the ‘new U.K. strain’ of SARS-CoV-2. 2) We’ve previously discussed our opinions on

Monica Gandhi MD, MPH

MonicaGandhi9

When will there be enough evidence that vaccines reduce asymptomatic carriage (e.g. risk of transmission) to be able to change guidelines for vaccinated people not being a risk to unvaccinated?

Kylie Ainslie

DrKAinslie

In round 4, we observed:- highest prevalence in 18 to 24 age group at 0.25% (0.16%, 0.41%), increasing from 0.08% (0.04%, 0.18%) in round 3. - lowest prevalence in 65+

Gupta Lab, Cambridge

GuptaR_lab

The E484K has indeed arrived on the background of B.1.1.7 and detected thanks to @CovidGenomicsUK. This figure shows number of sequences deposited over time. There may be independent acquisitions which

Adam Kucharski

AdamJKucharski

Why a SARS-CoV-2 variant that's 50% more transmissible would in general be a much bigger problem than a variant that's 50% more deadly. A short thread... 1/ As an example,

Alina Chan

Ayjchan

Going to briefly discuss a new SARS-CoV-2 preprint by the FDA, whose senior author said "was intended to investigate something that could only have happened in a laboratory" according to

Jeff still hasn't paid Taliban to kill US troops

NewJeffCT

As you can see, Donny Trump is still blaming China for Covid-19. Donny’s argument was that he was DUMB enough to believe China when they said they had the virus

Plum Remson 🙂😄🙂

PlumRemson

1/10 First off, TY for this thoughtful response. While not scientist/academic, I've spent many years studying literature on infectious disease/paradigms of perceived risk/responsibility, and I appreciate the nuance you are

Tom Connor

tomrconnor

So with all of the focus on the national surveillance of SARS-CoV-2 and the various variants that are circulating it can be easy to overlook the fact that the genome

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.